RedHill (RDHL) director Cabilly discloses major share and option holdings
Rhea-AI Filing Summary
RedHill Biopharma Ltd. director Cabilly Shmuel has filed an initial ownership report detailing a substantial equity stake in the company. He directly holds 105,200,000 Ordinary Shares, along with American Depositary Shares, restricted share units and stock options linked to additional Ordinary Shares.
The holdings include 10,520 unvested restricted share units, each tied to one American Depositary Share (ADS) that represents 10,000 Ordinary Shares, and 3,063 ADSs that are convertible at any time at the holder’s election and have no expiration date. He also holds fully vested stock options to purchase 90,000 Ordinary Shares at an exercise price of $4,870 per ADS expiring on March 25, 2030, and options to purchase 180,000 Ordinary Shares at an exercise price of $7,080 per ADS expiring on April 28, 2031.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | American Depositary Shares | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (1)
- Represents 10,520 unvested restricted share units ("RSUs"), each with respect to one American Depositary Share ("ADS"), which represents 10,000 ordinary shares, par value NIS 0.01 per share ("Ordinary Shares"), of RedHill Biopharma Inc. (the "Issuer"). The RSUs are subject to time-based vesting conditions and are settled in Ordinary Shares. Represents 3,063 ADSs, which are convertible at any time, at the holder's election and have no expiration date. Represents stock option to purchase 90,000 Ordinary Shares (equivalent to 9 ADSs), issued to the reporting person pursuant to the RedHill 2010 Option Plan. The shares underlying this stock option are fully vested and exercisable. The exercise price of this stock option is $4,870 per ADS and the option expires on March 25, 2030. Represents stock option to purchase 180,000 Ordinary Shares (equivalent to 18 ADSs), issued to the reporting person pursuant to the RedHill 2010 Option Plan. The shares underlying this stock option are fully vested and exercisable. The exercise price of this stock option is $7,080 per ADS and the option expires on April 28,2031.
